FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC – Abbott Laboratories Transaction History
FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC portfolio value:
$8.84M
portfolio value
FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1.09% | 987 shares | -980K | $96.76 | 91.42K |
Q2 2022 | share | Increase | +0.14% | 124 shares | -863K | $108.65 | 90.43K |
Q1 2022 | share | Increase | +1.21% | 1.08K shares | -1.86M | $118.36 | 90.31K |
Q4 2021 | share | Decrease | -0.92% | -829 shares | 1.91M | $141 | 89.23K |
Q3 2021 | share | Increase | +2.32% | 2.04K shares | 435K | $117.68 | 90.05K |
Q2 2021 | share | Decrease | -1.65% | -1.47K shares | -521K | $115.05 | 88.01K |
Q1 2021 | share | Increase | +0.60% | 538 shares | 985K | $118.49 | 89.49K |
Q4 2020 | share | Decrease | -1.16% | -1.04K shares | -55K | $107.81 | 88.95K |
Q3 2020 | share | Increase | +0.53% | 475 shares | 1.60M | $106.81 | 90.00K |
Q2 2020 | share | Decrease | -1.04% | -941 shares | 1.04M | $89.39 | 89.52K |
Q1 2020 | share | Decrease | -2.59% | -2.40K shares | -928K | $76.84 | 90.47K |
Q4 2019 | share | Decrease | -0.48% | -445 shares | 259K | $84.23 | 92.87K |
Q3 2019 | share | Decrease | -4.19% | -4.07K shares | -383K | $80.81 | 93.32K |
Q2 2019 | share | Decrease | -0.26% | -252 shares | 385K | $80.92 | 97.4K |
Q1 2019 | share | Decrease | -0.49% | -485 shares | 708K | $76.6 | 97.65K |
Q4 2018 | share | Increase | +0.44% | 427 shares | -70K | $68.98 | 98.13K |
Q3 2018 | share | Increase | +2.15% | 2.05K shares | 1.33M | $69.69 | 97.71K |
Q2 2018 | share | Increase | +0.32% | 305 shares | 120K | $57.68 | 95.65K |
Q1 2018 | share | Decrease | -0.89% | -853 shares | 224K | $56.4 | 95.35K |
Q4 2017 | share | Decrease | -4.62% | -4.66K shares | 108K | $53.46 | 96.20K |
Q3 2017 | share | Decrease | -0.12% | -125 shares | 473K | $49.74 | 100.86K |
Q2 2017 | share | Decrease | -0.08% | -79 shares | 420K | $45.07 | 100.99K |
Q1 2017 | share | Decrease | -1.20% | -1.22K shares | -89K | $40.93 | 101.07K |
Q4 2016 | share | 0.00% | 0 shares | 0 | $35.17 | 102.29K | |
Q3 2016 | share | Decrease | -0.14% | -140 shares | 551K | $38.48 | 102.29K |
Q2 2016 | share | Increase | +0.83% | 845 shares | -222K | $35.55 | 102.43K |
Q1 2016 | share | Increase | +3.92% | 3.83K shares | -141K | $37.6 | 101.58K |